← Back to Clinical Trials
Recruiting NCT07231146

NCT07231146 Interaction Between Dairy and Gut Hormone Response on Cognitive Performance in Children.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07231146
Status Recruiting
Phase —
Sponsor Toronto Metropolitan University
Condition Children
Study Type INTERVENTIONAL
Enrollment 48 participants
Start Date 2025-11-15
Primary Completion 2027-10

Eligibility & Interventions

Sex All sexes
Min Age 9 Years
Max Age 14 Years
Study Type INTERVENTIONAL
All Conditions
Interventions
Fat-Free MilkLow-Fat MilkFull-fat Milk

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 48 participants in total. It began in 2025-11-15 with a primary completion date of 2027-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to investigate the short-term effects of milk and yogurt of varying fat and protein content on cognitive performance in healthy children aged 9 - 14 years; and to provide insight into mechanisms by which dairy consumption may affect cognitive performance through gastrointestinal (GI) hormone responses. The investigators hypothesize that the consumption of dairy products, specifically their protein and fat components, will improve cognitive performance via its interaction with the gut-brain axis in children. Furthermore, the investigators hypothesize that all milk and yogurt products will enhance cognitive performance over 120- mins compared to snack skipping through its interaction with GI hormones, with a greater effect in higher fat containing milk and yogurt products.

Eligibility Criteria

Inclusion Criteria: * 9 to 14 years of age; * Normal weight is defined as being between the 5th and 85th percentile for age and biological sex at birth according to the Centers for Disease Control growth reference charts Exclusion Criteria: * Children with overweight/ obesity; * Children with food sensitivities or allergies to dairy, gluten or any foods used in the study; * Children with any diagnosed learning, emotional, or behavioural disabilities; * Children taking any medications that may influence cognitive performance.

Contact & Investigator

Principal Investigator

Nick Bellissimo, PhD

PRINCIPAL INVESTIGATOR

Toronto Metropolitan University

Frequently Asked Questions

Who can join the NCT07231146 clinical trial?

This trial is open to participants of all sexes, aged 9 Years or older, up to 14 Years, studying Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07231146 currently recruiting?

Yes, NCT07231146 is actively recruiting participants. Visit ClinicalTrials.gov or contact Toronto Metropolitan University to inquire about joining.

Where is the NCT07231146 trial being conducted?

This trial is being conducted at Toronto, Canada.

Who is sponsoring the NCT07231146 clinical trial?

NCT07231146 is sponsored by Toronto Metropolitan University. The principal investigator is Nick Bellissimo, PhD at Toronto Metropolitan University. The trial plans to enroll 48 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology